Original Research
Accepted on 15 Nov 2024
Discovery of novel PARP1/NRP1 dual-targeting inhibitors with strong antitumor potency
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454957
Type at least 3 characters
24,523 articles
Articles
Editorial
Accepted on 15 Nov 2024
Editorial: What does Experimental Pharmacology and Drug discovery look like in 2035?
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1504817
Review
Accepted on 15 Nov 2024
Microglia in morphine tolerance: cellular and molecular mechanisms and therapeutic potential
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499799
Original Research
Accepted on 15 Nov 2024
Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1517386
Editorial
Accepted on 15 Nov 2024
Editorial: Genomic Discoveries and Pharmaceutical Development in Urologic Tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1508979
Original Research
Accepted on 15 Nov 2024
Development of a UPLC-MS/MS method for the determination of Sulfatinib and its no interaction with myricetin in rats
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1498339
Original Research
Accepted on 15 Nov 2024
Efficacy of Oroxylin A in Ameliorating Renal Fibrosis with Emphasis on Sirt1 Activation and TGF-β/Smad3 Pathway Modulation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499012
Perspective
Accepted on 15 Nov 2024
The heat of longevity: sex differences in lifespan and body temperature
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1512526
Review
Accepted on 15 Nov 2024
Genotoxic and antigenotoxic medicinal plant extracts and their main phytochemicals: "A review"
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1448731
Original Research
Accepted on 15 Nov 2024
Quercetin alleviates ulcerative colitis through inhibiting CXCL8-CXCR1/2 axis: a network and transcriptome analysis
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1485255
Perspective
Accepted on 15 Nov 2024
Mitigating Paxlovid TM -Induced Drug-Drug Interaction Toxicity: An In Silico Insight ‡
in Predictive Toxicology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1496630
Case Report
Accepted on 15 Nov 2024
Case report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1448291
Original Research
Accepted on 15 Nov 2024
An exploratory study evaluated the 30 most commonly reported medications in the United States Food and Drug Administration's Adverse Event Reporting System that are associated with the occurrence of kidney stones
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377679
Original Research
Accepted on 15 Nov 2024
Effects of Pharmacogenomics-guided Treatment on Medication Adherence and the Rate of Antidepressant Switching in Major Depressive Disorder
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1501381
Original Research
Accepted on 15 Nov 2024
Chen's Peiyuan Tang and Premature Ovarian Failure: Unveiling the Mechanisms Through Network Pharmacology
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446707
Original Research
Published on 15 Nov 2024
Tetramethylpyrazine inhibits ferroptosis in spinal cord injury by regulating iron metabolism through the NRF2/ARE pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503064
- 155 views